Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study

BACKGROUND: Prescription medications such as selective serotonin reuptake inhibitors (SSRIs), commonly used to treat depression, are associated with weight gain. The role of pharmacogenomics in predicting SSRI-induced weight gain is unclear. METHODS: In this retrospective cohort study from participa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricardo-Silgado, Maria L., Singh, Sneha, Cifuentes, Lizeth, Decker, Paul A., Gonzalez-Izundegui, Daniel, Moyer, Ann M., Hurtado, Maria D., Camilleri, Michael, Bielinski, Suzette J., Acosta, Andres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317126/
https://www.ncbi.nlm.nih.gov/pubmed/35879764
http://dx.doi.org/10.1186/s12916-022-02433-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317126/
https://www.ncbi.nlm.nih.gov/pubmed/35879764
http://dx.doi.org/10.1186/s12916-022-02433-x

Ejemplares similares